Lauren Gunasti

Stereotactic Body Radiotherapie With Pembrolizumab in Programmed Cell Death Protein 1 Inhibitor–Refractory Recurrent or Gemetastaseerd Hoofd-hals Squamous Cell Carcinoma: A Fase 2-Trial

Durvalumab plus tremelimumab met of zonder RT bij NSCLC: COAST fase II